NCM · Biotechnology

ALLR (ALLR) Stock

$1.39 -0.71% NCM: ALLR Healthcare

Valuation

MetricValue
Price$1.39
Market Cap$22.12M
P/E Ratio-1.91
P/B Ratio2.37
P/S Ratio68.72
EPS (TTM)$-0.78
52-Week High$2.35
52-Week Low$0.77
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-110.00%
ROA-61.11%
ROCE-130.00%
Gross Margin1.08%
Operating Margin-35.53%
Net Margin-32.61%
Debt/Equity3.11
Current Ratio2.25

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-27.0M$-34.0M$-17.0M$-27.0M$-13.0M
Net Profit$-27.0M$-16.0M$-12.0M$-25.0M$-11.0M
EPS$-79074.18$-31799.09$-6031.31$-15.79$-0.78
Op Margin————-3939.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$50.0M$15.0M$12.0M$23.0M$18.0M
Total Liabilities$31.0M$13.0M$15.0M$11.0M$8.0M
Cash$20.0M$2.0M$0$20.0M$15.0M
Borrowings$1.0M$4.0M$1.0M$1.0M$1.0M

Latest News

Allarity Therapeutics Announces CLIA Certification, Clearing the Path for Advancing DRP® Testing for FDA Registration GlobeNewswire · Jul 7, 2026 Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year? Zacks · Jul 6, 2026 Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic GlobeNewswire · Jun 30, 2026 Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year? Zacks · Jun 19, 2026 Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026 GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-15.0M$-17.0M$-13.0M$-17.0M$-15.0M
Investing Cash Flow$1.0M$1.0M$0$-1.0M$0
Financing Cash Flow$1.0M$-1.0M$2.0M$-3.0M$-3.0M
Net Cash Flow$19.0M$-18.0M$-2.0M$19.0M$-5.0M
Free Cash Flow$-15.0M$-17.0M$-13.0M$-18.0M$-15.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-70.44%
Quick Ratio1.23
Interest Coverage—
Return 1Y16.83%
Return 3Y-99.93%
Return 5Y—

Ownership

Insiders Held4.19%
Institutions Held5.98%
Institutions Float Held6.24%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC228,0842026-03-31
Geode Capital Management, LLC190,3932026-03-31
Vanguard Capital Management LLC171,7952026-03-31
State Street Corporation137,6002026-03-31
Vanguard Fiduciary Trust Co74,9132026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BCTX $3.53 +1.73% -0.04 $6.65M 0.00%
CASICASI Pharmaceuticals, Inc. $0.15 +3.08% -0.07 $2.33M 0.00%
CING $4.52 -2.59% -1.08 $25.34M 0.00%
CLSDClearside Biomedical, Inc. $0.41 +0.00% -0.11 $2.15M 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%

About ALLR

ALLR is led by CEO Thomas H. Jensen, employs 6 people, headquartered in US, publicly traded since 2021.

ALLR stock trades at $1.39 with a market capitalization of $22.12M. The stock is valued at a price-to-earnings (P/E) ratio of -1.91, price-to-book of 2.37, price-to-sales of 68.72. Over the past 52 weeks the stock has ranged between $0.77 and $2.35, and currently trades 40.9% below its 52-week high.

On profitability, ALLR generates a return on equity (ROE) of -110.00%, return on capital employed of -130.00%, an operating margin of -35.53%, a net profit margin of -32.61%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides